Patent ID: 6337328
Filing Date: 2002-01-08
Classification: A61K,A61P,C07B,C07C,C07D

Abstract:
A method of treating or preventing sexual dysfunction which comprises administering to a patient in need of such treatment or prevention a therapeutically or prophylactically effective amount of a bupropion metabolite, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate thereof, wherein the bupropion metabolite is 2-(3-chlorophenyl)-2-hydroxy-3,5,5-trimethyl-morpholinol, 1-(3-chlorophenyl)-2-[(1,1-dimethylethanol)amino]-1-propanol, and 1-(3-chlorophenyl)-2-[(1,1-dimethylethanol)amino]-1-propanone.